Printer Friendly

American Oriental Bioengineering Inc gets NYSE non-compliance notice.

M2 EQUITYBITES-April 9, 2012-American Oriental Bioengineering Inc gets NYSE non-compliance notice(C)2012 M2 COMMUNICATIONS

Pharmaceutical company American Oriental Bioengineering Inc (NYSE:AOB) said on Friday that it is not in compliance with New York Stock Exchange rules due to its failure to timely file its Annual Report on Form 10-K with the US Securities and Exchange Commission.

Under NYSE rules, when a company does not comply with annual report filing requirements, the NYSE allows a company an additional six months to file its annual report in order to regain compliance.

If American Oriental Bioengineering fails to file its annual report on or before 29 October 2012, the NYSE may, in its sole discretion, allow the company's securities to remain listed for up to an additional six months or may commence suspension and delisting procedures.

((Comments on this story may be sent to

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Apr 9, 2012
Previous Article:Zentric withdraws from EPC agreement to build solar power plant in Arizona.
Next Article:Par Pharmaceutical Companies Inc announces shipment of generic wakefulness-prompting tablets, Provigil.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters